The use of convection-enhanced delivery with liposomal toxins in neurooncology

Toxins

Volumn 3, Issue 4, 2011, Pages 369-397

  Fiandaca, Massimo S ^a   Berger, Mitchel S ^a   Bankiewicz, Krystof S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood brain barrier; Convection enhanced delivery; Diffusion; Glioma; Liposome; Neurooncology

Indexed keywords

ACRIDINE; ANTINEOPLASTIC AGENT; CARMUSTINE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; FENRETINIDE; INTERLEUKIN 12; IRINOTECAN; LIPOSOMAL TOXIN; LIPOSOME; MACROGOL; POLYMER; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; CANCER GRADING; CENTRAL NERVOUS SYSTEM TUMOR; CONVECTION ENHANCED DELIVERY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; ENCAPSULATION; ENDOCYTOSIS; EXTRACELLULAR MATRIX; GLIOBLASTOMA; GLIOMA; HUMAN; HYDROPHILICITY; LIPID MEMBRANE; LIPOPHILICITY; LIPOSOMAL GENE DELIVERY SYSTEM; NONHUMAN; PHAGOCYTOSIS; REVIEW;

BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; CONVECTION; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES;

EID: 79955634142     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins3040369     Document Type: Review

References (197)

1. Scherrmann, J.M. Drug delivery to brain via the blood-brain barrier. Vasc. Pharmacol. 2002, 38, 349-354.
2. Ballabh, P.; Braun, A.; Nedergaard, M. The blood-brain barrier: An overview. Structure, regulation, and clinical implications. Neurobiol. Dis. 2004, 16, 1-13.
3. Persidsky, Y.; Ramirez, S.H.; Haorah, J.; Kanmongne, G.D. Blood-brain barrier: Structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol. 2006, 1, 223-236.
4. Greib, P.; Forster, R.E.; Strome, D.; Goodwin, C.W.; Pape, P.C. O2 exchange between blood and brain tissues studied with 18O2 indicator-dilution technique. J. Appl. Physiol. 1985, 58, 1929-1941.
5. Pardridge, W.M.; Eisenberg, J.; Yang, J. Human blood-brain barrier insulin receptor. J. Neurochem. 1985, 44, 1771-1778.
6. Zhang, Y.; Pardridge, W.M. Rapid transferrin efflux from brain to blood across the blood-brain barrier. J. Neurochem. 2001, 76, 1597-1600.
7. Rejman, J.; Oberle, V.; Zuhorn, I.S.; Hoekstra, D. Size-dependent internalization of particles via the pathways of clathrinand caveolae-mediated endocytosis. Biochem. J. 2004, 377, 159-169.
8. Brightman, M.W.; Broadwell, R.D. The morphological approach to the study of normal and abnormal brain permeability. Adv. Exp. Med. Biol. 1976, 69, 41-54.
9. Shivers, R.R.; Edmonds, C.L.; Del Maestro, R.F. Microvascular permeability in induced astrocytomas and peritumor neuropil of rat brain. A high-voltage electron microscope-protein tracer study. Acta Neuropathol. 1984, 64, 192-202.
10. Vick, N.A.; Khandekar, J.D.; Bigner, D.D. Chemotherapy of brain tumors: The "blood-brain barrier" is not a factor. Arch. Neurol. 1977, 34, 523-526.
11. Donelli, M.G.; Zucchetti, M.; D'Incalci, M. Do anticancer agents reach the tumor target in the human brain? Cancer Chemother. Pharmacol. 1992, 30, 251-260.
12. Stewart, D.J. A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors. J. Neuro-Oncol. 1994, 20, 121-139.
13. Groothuis, D.R. The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery. Neuro-Oncology 2000, 2, 45-59.
14. Groothuis, D.R.; Lippitz, B.E.; Fekete, I.; Schlageter, K.E.; Molnar, P.; Colvin, O.M.; Roe, C.R.; Bigner, D.D.; Friedman, H.S. The effect of an amino acid-lowering diet on the rate of melphalan entry into brain and xenotransplanted glioma. Cancer Res. 1992, 52, 5590-5596.
15. Pardridge, W.M.; Boado, R.J.; Kang, Y.S. Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo. Proc. Natl. Acad. Sci. USA 1995, 92, 5592-5596.
16. van de Waterbeemd, H.; Camenish, G.; Folkers, G.; Chretien, J.R.; Raevsky, O.A. Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J. Drug Target. 1998, 6, 151-165.
17. Rapoport, S.J.; Thompson, H.K. Osmotic opening of the blood-brain barrier in the monkey without associated neurological de cits. Science 1973, 180, 971.
18. Neuwelt, E.A.; Dahlborg, S.A. Blood-brain barrier disruption in the treatment of brain tumors: Clinical implications. In Implications of the Blood-Brain Barrier and Its Manipulation; Neuwelt, E.A., Ed.; Plenum Medical Book Company: New York, NY, USA, 1989; Volume 2, pp. 195-262.
19. Black, K.L.; Cloughesy, T.; Huang, S.C.; Gobin, Y.P.; Zhou, Y.; Grous, J.; Nelson, G.; Farahani, K.; Hoh, C.K.; Phelps, M. Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. J. Neurosurg. 1997, 86, 603-609.
20. Brown, M.T.; Coleman, R.E.; Friedman, A.H.; Friedman, H.S.; McLendon, R.E.; Reiman, R.; Felsberg, G.J.; Tien, R.D.; Bigner, S.H.; Zalutsky, M.R.; et al. Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: Phase I trial results. Clin. Cancer Res. 1996, 2, 963-972.
21. Blasberg, R.G. Methotrexate, cytosine arabinoside, and BCNU concentration in brain after ventriculocisternal perfusion. Cancer Treat. Rep. 1977, 61, 625-631.
22. Groothuis, D.R.; Levy, R.M. The entry of antiviral and antiretroviral drugs into the central nervous system. J. Neurovirol. 1997, 3, 387-400.
23. Patlak, C.S.; Fenstermacher, J.D. Measurements of dog bloodbrain transfer constants by ventriculocisternal perfusion. Amer. J. Physiol. 1975, 229, 877-884.
24. Tomita, T. Interstitial chemotherapy for brain tumors: Review. J. Neuro-Oncol. 1991, 10, 57-74.
25. de Lange, E.C.M.; Danhof, M.; de Boer, A.G.; Breimer, D.D. Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier. Brain Res. Rev. 1997, 25, 27-49.
26. Parsons, L.H.; Justice, J.B., Jr. Quantitative approaches to in vivo brain microdialysis. Crit. Rev. Neurobiol. 1994, 8, 189-220.
27. de Lange, E.C.M.; de Boer, A.G.; Breimer, D.D. Microdialysis for pharmacokinetic analysis of drug transport to the brain. Adv. Drug. Deliv. Rev. 1999, 36, 211-227.
28. Cao, X.; Shoichet, M.S. Delivering neuroactive molecules from biodegradable microspheres for application in central nervous system disorders. Biomaterials 1999, 20, 329-339.
29. Olivi, A.; Brem, H. Interstitial chemotherapy with sustained release polymer systems for the treatment of malignant gliomas. Recent Results Canc. Res. 1994, 135, 149-154.
30. Groothuis, D.R.; Benalcazar, H.; Allen, C.V.; Wise, R.M.; Dills, C.; Dobrescu, C.; Rothholtz, V.; Levy, R.M. Comparison of cytosine arabinoside delivery to rat brain by intravenous, intrathecal, intraventricular and intraparenchymal routes of administration. Brain Res. 2000, 856, 281-290.
31. Patel, M.M.; Goyal, B.R.; Bhadada, S.V.; Bhatt, J.D.; Amin, A.F. Getting into the brain: Approaches to enhance brain drug delivery. CNS Drugs 2009, 23, 35-58.
32. Schantz, E.J.; Lauffer, M.A. Diffusion measurements in agar gel. Biochemistry 1962, 1, 658-663.
33. Jain, R.K. Transport of molecules in the tumor interstitium: A review. Cancer Res. 1987, 47, 3039-3051.
34. Jain, R.K. Delivery of novel therapeutic agents in tumors: Physiological barriers and strategies. J. Natl. Cancer Inst. 1989, 81, 570-576.
35. Fung, L.K.; Ewend, M.G.; Sills, A.; Sipos, E.P.; Thompson, R.; Watts, M.; Colvin, O.M.; Brem, H.; Saltzman, W.M. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res. 1998, 58, 672-684.
36. Kroin, J.S.; Penn, R.D. Intracerebral chemotherapy: Chronic microinfusion of cisplatin. Neurosurgery 1982, 10, 349-354.
37. Sendelbeck, S.L.; Urquhart, J. Spatial distribution of dopamine, methotrexate and antipyrine during continuous intracerebral microperfusion. Brain Res. 1985, 328, 251-258.
38. Morrison, P.F.; Dedrick, R.L. Transport of cisplatin in rat brain following microinfusion: An analysis. J. Pharm. Sci. 1986, 75, 120-128.
39. Fiandaca, M.S.; Forsayeth, J.R.; Dickinson, P.J.; Bankiewicz, K.S. Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics 2008, 5, 123-127.
40. Sykova, E.; Nicholson, C. Diffusion in brain extracellular space. Physiol. Rev. 2008, 88, 1277-1340.
41. Vargova, L.; Homola, A.; Zamecnik, J.; Tichy, M.; Benes, V.; Sykova, E. Diffusion parameters of the extracellular space in human gliomas. Glia 2003, 42, 77-88.
42. Zamecnik, J.; Vargova, L.; Homola, A.; Kodet, R.; Sykova, E. Extracellular matrix glycoproteins and diffusion barriers in human astrocytic tumours. Neuropathol. Appl. Neurobiol. 2004, 30, 338-350.
43. Sykova, E. Diffusion properties of the brain in health and disease. Neurochem. Int. 2004, 45, 453-466.
44. Bobo, R.H.; Laske, D.W.; Akbasak, A.; Morrison, P.F.; Dedrick, R.L.; Oldfield, E.H. Convection-enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sci. USA 1994, 91, 2076-2080.
45. Morrison, P.F.; Laske, D.W.; Bobo, H.; Oldfield, E.H.; Dedrick, R.L. High-flow microinfusion: Tissue penetration and pharmacodynamics. Amer. J. Physiol. 1994, 266, 292-305.
46. Szerlip, N.J.; Walbridge, S.; Yang, L.; Morrison, P.F.; Degen, J.W.; Jarrell, S.T.; Kouri, J.; Kerr, P.B.; Kotin, R.; Oldfield, E.H.; et al. Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles. J. Neurosurg. 2007, 107, 560-567.
47. Krauze, M.T.; Forsayeth, J.; Park, J.W.; Bankiewicz, K.S. Real-time imaging and quantification of brain delivery of liposomes. Pharm. Res. 2006, 23, 2493-2504.
48. Hadaczek, P.; Yamashita, Y.; Mirek, H.; Tamas, L.; Bohn, M.C.; Noble, C.; Park, J.W.; Bankiewicz, K. The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol. Ther. 2006, 14, 69-78.
49. Hamilton, J.F.; Morrison, P.F.; Chen, M.Y.; Harvey-White, J.; Pernaute, R.S.; Phillips, H.; Oldfield, E.; Bankiewicz, K.S. Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin. Exp. Neurol. 2001, 168, 155-161.
50. Neeves, K.B.; Sawyer, A.J.; Foley, C.P.; Saltzman, W.M.; Olbricht, W.L. Dilation and degradation of the brain extracellular matrix enhances penetration of infused polymer nanoparticles. Brain Res. 2007, 1180, 121-132.
51. Nguyen, J.B.; Sanchez-Pernaute, R.; Cunningham, J.; Bankiewicz, K.S. Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. Neuroreport 2001, 12, 1961-1964.
52. Morrison, P.F.; Chen, M.Y.; Chadwick, R.S.; Lonser, R.R.; Oldfield, E.H. Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics. Amer. J. Physiol. 1999, 277, 1218-1229.
53. Chen, M.Y.; Lonser, R.R.; Morrison, P.F.; Governale, L.S.; Oldfield, E.H. Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J. Neurosurg. 1999, 90, 315-320.
54. Krauze, M.T.; Saito, R.; Noble, C.; Tamas, M.; Bringas, J.; Park, J.W.; Berger, M.S.; Bankiewicz, K.S. Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J. Neurosurg. 2005, 103, 923-929.
55. Fiandaca, M.S.; Varenika, V.; Eberling, J.; McKnight, T.R.; Bringas, J.; Pivirotto, P.; Beyer, J.; Hadaczek, P.; Forsayeth, J.; Bowers, W.J.; et al. Real-time MR imaging of adeno-associated viral vector delivery to the primate brain. Neuroimage 2009, 47, 27-35.
56. Nguyen, T.T.; Pannu, Y.S.; Sung, C.; Dedrick, R.L.; Walbridge, S.; Brechbiel, M.W.; Garmestani, K.; Beitzel, M.; Yordanov, A.T.; Oldfield, E.H. Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J. Neurosurg. 2003, 98, 584-590.
57. Saito, R.; Krauze, M.T.; Bringas, J.R.; Noble, C.; McKnight, T.R.; Jackson, P.; Wendland, M.F.; Mamot, C.; Drummond, D.C.; Kirpotin, D.B.; et al. Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp. Neurol. 2005, 196, 381-389.
58. Krauze, M.T.; McKnight, T.R.; Yamashita, Y.; Bringas, J.; Noble, C.O.; Saito, R.; Geletneky, K.; Forsayeth, J.; Berger, M.S.; Jackson, P.; et al. Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Res. Protoc. 2005, 16, 20-26.
59. Murad, G.J.; Walbridge, S.; Morrison, P.F.; Garmestani, K.; Degen, J.W.; Brechbiel, M.W.; Oldfield, E.H.; Lonser, R.R. Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin. Clin. Cancer Res. 2006, 12, 145-151.
60. Lonser, R.R.; Schiffman, R.; Robison, R.A.; Butman, J.A.; Quezado, Z.; Walker, M.L.; Morrison, P.F.; Walbridge, S.; Murray, G.J.; Park, D.M.; et al. Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease. Neurology 2007, 68, 254-261.
61. Lonser, R.R.; Warren, K.E.; Butman, J.A.; Quezado, Z.; Robison, R.A.; Walbridge, S.; Schiffman, R.; Merrill, M.; Walker, M.L.; Park, D.M.; et al. Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J. Neurosurg. 2007, 107, 190-197.
62. Varenika, V.; Dickenson, P.; Bringas, J.; LeCouteur, R.; Higgins, R.; Park, J.; Fiandaca, M.; Berger, M.; Sampson, J.; Bankiewicz, K.S. Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery. J. Neurosurg. 2008, 109, 874-880.
63. Gill, S.S.; Patel, N.K.; Hotton, G.R.; O'Sullivan, K.; McCarter, R.; Bunnage, M.; Brooks, D.J.; Svendsen, C.N.; Heywood, P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 2003, 9, 589-595.
64. Patel, N.K.; Bunnage, M.; Plaha, P.; Svendsen, C.N.; Heywood, P.; Gill, S.S. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann. Neurol. 2005, 57, 298-302.
65. Love, S.; Plaha, P.; Patel, N.K.; Hotton, G.R.; Brooks, D.J.; Gill, S.S. Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat. Med. 2005, 11, 703-705.
66. Marks, W.J.; Bartus, R.T.; Siffert, J.; Davis, C.S.; Lozano, A.; Boulis, N.; Vitek, J.; Stacy, M.; Turner, D.; Verhagen, L.; et al. Gene delivery of AAV2-neurturin for Parkinson's disease: A double-blind, randomised, controlled trial. Lancet Neurol. 2010, 9, 1164-1172.
67. Kunwar, S.; Pai, L.H.; Pastan, I. Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells. J. Neurosurg. 1993, 79, 569-576.
68. Laske, D.W.; Youle, R.J.; Oldfield, E.H. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat. Med. 1997, 3, 1362-1368.
69. Rand, R.W.; Kreitman, R.J.; Patronas, N.; Varricchio, F.; Pastan, I.; Puri, R.K. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma. Exp. Neurol. 2000, 6, 2157-2165.
70. Sampson, J.H.; Akabani, G.; Archer, G.E.; Bigner, D.D.; Berger, M.S.; Friedman, A.H.; Friedman, H.S.; Herndon, J.E., II; Kunwar, S.; Marcus, S.; McLendon, R.E.; Paolino, A.; Penne, K.; Provenzale, J.; Quinn, J.; Reardon, D.A.; Rich, J.; Stenzel, T.; Tourt-Uhlig, S.; Wikstrand, C.; Wong, T.; Williams, R.; Yuan, F.; Zalutsky, M.R.; Pastan, I. Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors. J. Neuro-Oncol. 2003, 65, 27-35.
71. Weber, F.; Asher, A.; Bucholz, R.; Berger, M.; Prados, M.; Chang, S.; Bruce, J.; Hall, W.; Rainov, N.G.; Westphal, M.; et al. Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma. J. Neuro-Oncol. 2003, 64, 125-137.
72. Weber, F.W.; Floeth, F.; Asher, A.; Bucholz, R.; Berger, M.; Prados, M.; Chang, S.; Bruce, J.; Hall, W.; Rainov, N.G.; et al. Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma. Acta Neurochir. 2003, 88, 93-103.
73. Patel, S.J.; Shapiro, W.R.; Laske, D.W.; Jensen, R.L.; Asher, A.L.; Wessels, B.W.; Carpenter, S.P.; Shan, J.S. Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery 2005, 56, 1243-1252.
74. Fiandaca, M.S.; Bankiewicz, K.S. Gene therapy for Parkinson's disease: From nonhuman primates to humans. Curr. Opin. Mol. Ther. 2010, 12, 519-529.
75. Sampson, J.H.; Archer, G.; Pedain, C.; Wembacher-Schröder, E.; Westphal, M.; Kunwar, S.; Vogelbaum, M.A.; Coan, A.; Herndon, J.E.; Raghavan, R.; et al. Poor drug distribution as a possible explanation for the results of the PRECISE trial. J. Neurosurg. 2010, 113, 301-309.
76. Valles, F.; Fiandaca, M.S.; Bringas, J.; Dickinson, P.J.; LeCouteur, R.A.; Higgins, R.J.; Berger, M.; Forsayeth, J.; Bankiewicz, K.S. Anatomical compression caused by high-volume convection-enhanced delivery to the brain. Neurosurgery 2009, 65, 579-586.
77. Behin, A.; Hoang-Xuan, K.; Carpentier, A.F.; Delattre, J.Y. Primary brain tumours in adults. Lancet 2003, 361, 323-331.
78. Zamecnik, J. The extracellular space and matrix of gliomas. Acta Neuropathol. 2005, 110, 435-442.
79. Baxter, L.T.; Jain, R.K. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc. Res. 1989, 37, 77-104.
80. Smith, J.H.; Humphrey, J.A. Interstitial transport and transvascular fluid exchange during infusion into brain and tumor tissue. Microvasc. Res. 2007, 73, 58-73.
81. Ali, M.J.; Navlitloha, Y.; Vavra, M.W.; Kang, E.W.Y.; Itskovitch, A.C.; Molnar, P.; Levy, R.M.; Groothuis, D.R. Isolation of drug delivery from drug effect: Problems of optimizing drug delivery parameters. Neuro Oncol. 2006, 8, 109-118.
82. Gregoriadis, G. Engineering liposomes for drug delivery: Progress and problems. Trends Biotechnol. 1995, 13, 527-537.
83. Torchilin, V.P. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 2001, 73, 137-172.
84. Yang, Y.Y.; Wang, Y.; Powell, R.; Chan, P. Polymeric core-shell nanoparticles for therapeutics. Clin. Exp. Pharmacol. Physiol. 2006, 33, 557-562.
85. Bangham, A.D.; Standish, M.M.; Miller, N. Cation permeability of phospholipid model membranes: Effect of narcotics. Nature 1965, 208, 1295-1297.
86. Bangham, A.D.; Standish, M.M.; Watkins, J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 1965, 13, 238-252.
87. Bangham, A.D. Lipid bilayers and biomembranes. Annu. Rev. Biochem. 1972, 41, 753-776.
88. Torchilin, V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 2005, 4, 145-160.
89. Chapman, D. Lipid dynamics in cell membranes. In Cell Membranes: Biochemistry, Cell Biology and Pathology; Weissmann, G.; Claiborne, R., Eds.; Hospital Practice Publishing Company: New York, NY, USA, 1975; pp. 13-22.
90. Chapman, D.; Benga, G. Biomembrane fluidity-studies of model and natural membranes. In Biological Membranes; Chapman, D., Ed.; Academic Press: London, UK, 1984; Volume 5, pp. 1-56.
91. Kates, M.; Manson, L.A. Membrane Fluidity. In Biomembranes; Plenum Press: New York, NY, USA, 1984; Volume 12.
92. Haines, T.H. Do sterols reduce proton and sodium leaks through lipid bilayers? Prog. Lipid Res. 2001, 40, 299-324.
93. Panwar, P.; Pandey, B.; Lakhera, P.C.; Singh, K.P. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int. J. Nanomed. 2010, 5, 101-108.
94. Szoka, F.J.; Papahadjopoulos, D. Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu. Rev. Biophys. Bioeng. 1980, 9, 467-508.
95. Penwar, P.; Pandey, B.; Lakhera, P.C.; Singh, K.P. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int. J. Nanomed. 2010, 9, 101-108.
96. Wang, H.; Zhao, P.; Liang, X.; Gong, X.; Song, T.; Niu, R.; Chang, J. Folate-PEG coated cationic modified chitosan-Cholesterol liposomes for tumor-targeted drug delivery. Biomaterials 2010, 31, 4129-4138.
97. Pagano, R.E.; Weinstein, J.N. Interaction of liposomes with mammalian cells. Annu. Rev. Biophys. Bioeng. 1978, 7, 435-468.
98. Samad, A.; Sultana, Y.; Aqil, M. Liposomal drug delivery systems: An update review. Curr. Drug Deliv. 2007, 4, 297-305.
99. Deamer, D.; Bangham, A.D. Large volume liposomes by an ether vaporization method. Biochim. Biophys. Acta 1976, 443, 629-634.
100. Gregoriadis, G. Engineering liposomes for drug delivery: Progress and problems. Trends Biotechnol. 1995, 13, 527-537.
101. Torchilin, V.P. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 2001, 73, 137-172.
102. Yang, Y.Y.; Wang, Y.; Powell, R.; Chan, P. Polymeric core-shell nanoparticles for therapeutics. Clin. Exp. Pharmacol. Physiol. 2006, 33, 557-562.
103. Bangham, A.D.; Standish, M.M.; Miller, N. Cation permeability of phospholipid model membranes: Effect of narcotics. Nature 1965, 208, 1295-1297.
104. Bangham, A.D.; Standish, M.M.; Watkins, J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 1965, 13, 238-252.
105. Bangham, A.D. Lipid bilayers and biomembranes. Annu. Rev. Biochem. 1972, 41, 753-776.
106. Torchilin, V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 2005, 4, 145-160.
107. Chapman, D. Lipid dynamics in cell membranes. In Cell Membranes: Biochemistry, Cell Biology and Pathology; Weissmann, G.; Claiborne, R., Eds.; Hospital Practice Publishing Company: New York, NY, USA, 1975; pp. 13-22.
108. Chapman, D.; Benga, G. Biomembrane fluidity-studies of model and natural membranes. In Biological Membranes; Chapman, D., Ed.; Academic Press: London, UK, 1984; Volume 5, pp. 1-56.
109. Kates, M.; Manson, L.A. Membrane Fluidity. In Biomembranes; Plenum Press: New York, NY, USA, 1984; Volume 12.
110. Haines, T.H. Do sterols reduce proton and sodium leaks through lipid bilayers? Prog. Lipid Res. 2001, 40, 299-324.
111. Panwar, P.; Pandey, B.; Lakhera, P.C.; Singh, K.P. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int. J. Nanomed. 2010, 5, 101-108.
112. Szoka, F.J.; Papahadjopoulos, D. Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu. Rev. Biophys. Bioeng. 1980, 9, 467-508.
113. Penwar, P.; Pandey, B.; Lakhera, P.C.; Singh, K.P. Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes. Int. J. Nanomed. 2010, 9, 101-108.
114. Wang, H.; Zhao, P.; Liang, X.; Gong, X.; Song, T.; Niu, R.; Chang, J. Folate-PEG coated cationic modified chitosan-Cholesterol liposomes for tumor-targeted drug delivery. Biomaterials 2010, 31, 4129-4138.
115. Pagano, R.E.; Weinstein, J.N. Interaction of liposomes with mammalian cells. Annu. Rev. Biophys. Bioeng. 1978, 7, 435-468.
116. Samad, A.; Sultana, Y.; Aqil, M. Liposomal drug delivery systems: An update review. Curr. Drug Deliv. 2007, 4, 297-305.
117. Deamer, D.; Bangham, A.D. Large volume liposomes by an ether vaporization method. Biochim. Biophys. Acta 1976, 443, 629-634.
118. Schieren, H.; Rudolph, S.; Finkelstein, M.; Coleman, P.; Weissmann, G. Comparison of large unilamellar vesicles prepared by a petroleum ether vaporization method with multilamellar vesicles: ESR, diffusion and entrapment analyses. Biochim. Biophys. Acta 1978, 542, 137-153.
119. Szoka, F.J.; Papahadjopoulos, D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc. Natl. Acad. Sci. USA 1978, 75, 4194-4198.
120. Pick, U. Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. Arch. Biochem. Biophys. 1981, 212, 186-194.
121. Lasic, D.D. The spontaneous formation of unilamellar vesicles. J. Colloid Interf. Sci. 1988, 124, 428-435.
122. Gould-Fogerite, S.; Mannino, R.J. Preparation of large unilamellar liposomes with high entrapment yield by rotary dialysis or agarose plug diffusion. In Liposome Technology. Liposome Preparation and Related Techniques; Gregoriadis, G., Ed.; CRC Press: Boca Raton, FL, USA, 1993; Volume 1, pp. 67-79.
123. Kikuchi, H.; Yamauchi, H.; Hirota, S. A polyol dilution method for mass production of liposomes. J. Liposome Res. 1994, 4, 71-91.
124. Talsma, H.; van Steenbergen, M.J.; Borchert, J.C.H.; Crommelin, D.J.A. A novel technique for the one-step preparation of liposomes and nonionic surfactant vesicles without the use of organic solvents. Liposome formation in a continuous gas stream: The bubble method. J. Pharm. Sci. 1994, 83, 276-280.
125. Vemuri, S.; Rhodes, C.T. Preparation and characterization of liposomes as therapeutic delivery systems: A review. Pharm. Acta Helv. 1995, 70, 95-111.
126. Lasic, D.D.; Joannic, R.; Keller, B.C.; Frederik, P.M.; Auvray, L. Spontaneous vesiculation. Adv. Colloid Interface Sci. 2001, 89-90, 337-349.
127. Mozafari, M.R.; Reed, C.J.; Rostron, C. Development of non-toxic liposomal formulations for gene and drug delivery to the lung. Technol. Health Care 2002, 10, 342-344.
128. Mozafari, M.R.; Reed, C.J.; Rostron, C.; Kocum, C.; Piskin, E. Construction of stable anionic liposome-plasmid particles using the heating method: A preliminary investigation. Cell. Mol. Biol. Lett. 2002, 7, 923-927.
129. Mozafari, M.R.; Reed, C.J.; Rostron, C.; Martin, D.S. Transfection of human airway epithelial cells using a lipid-based vector prepared by the heating method. J. Aerosol Med. 2004, 17, 100.
130. Mozafari, M.R. Liposomes: An overview of manufacturing techniques. Cell. Mol. Biol. Lett. 2005, 10, 711-719.
131. Barenholz, Y.; Gibbes, D.; Litman, B.J.; Goll, J.; Thompson, T.E.; Carlson, R.D. A simple method for the preparation of homogeneous phospholipid vesicles. Biochemistry 1977, 16, 2806-2810.
132. Hope, M.J.; Bally, M.B.; Webb, G.; Cullis, P.R. Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim. Biophys. Acta 1985, 812, 55-65.
133. MacDonald, R.C.; MacDonald, R.I.; Menco, B.P.M.; Takeshita, K.; Subbarao, N.K.; Hu, L. Small volume extrusion apparatus for preparation of large unilamellar vesicles. Biochim. Biophys. Acta 1991, 1061, 297-303.
134. Klibanov, A.L.; Murayama, K.; Torchilin, V.P.; Huang, L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990, 268, 235-237.
135. Murayama, K.; Kennel, S.J.; Huang, L. Lipid composition is important for highly efficient target binding and retention of immunoliposomes. Proc. Natl. Acad. Sci. USA 1990, 87, 5744-5748.
136. Murayama, K. PEG-Immunoliposoome. Biosci. Rep. 2002, 22, 251-266.
137. Torchilin, V.P.; Omelyanenko, V.G.; Papisov, M.I.; Bogdanov, A.A.J.; Trubetskoy, V.S.; Herron, J.N.; Gentry, C.A. Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim. Biophys. Acta 1994, 1195, 11-20.
138. Pedroso de Lima, M.C.; Girao da Cruz, M.T.; Cardoso, A.L.C.; Simoes, S.; Pereira de Almeida, L. Liposomal and viral vectors for gene therapy of the central nervous system. Curr. Drug Targets CNS Neurol. Disord. 2005, 4, 453-465.
139. Black, C.; Gregoriadis, G. Intracellular fate and effect of liposome-entrapped actinomycin-d injected into rats. Biochem. Soc. Trans. 1974, 2, 869-871.
140. Hillaireau, H.; Couvreur, P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci. 2009, 66, 2873-2896.
141. Aderem, A.; Underhill, D. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 1999, 17, 593-623.
142. Rabinovitch, M. Professional and nonprofessional phagocytes-an introduction. Trends Cell Biol. 1995, 5, 85-87.
143. Owens, D.; Peppas, N. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 2006, 307, 93-102.
144. Vonarbourg, A.; Passirani, C.; Saulnier, P.; Benoit, J. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 2006, 27, 4356-4373.
145. Korn, E.D.; Weisman, R.A. Phagocytosis of latex beads by Acanthamoeba. II. Electron microscopic study of the initial events. J. Cell Biol. 1967, 34, 219-227.
146. Otsuka, H.; Nagasaki, Y.; Kataoka, K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev. 2003, 55, 403-419.
147. Mukherjee, S.; Ghosh, R.N.; Maxfield, F.R. Endocytosis. Physiol. Rev. 1997, 77, 759-803.
148. Conner, S.D.; Schmid, S.L. Regulated portals of entry into the cell. Nature 2003, 422, 37-44.
149. Swanson, J.A.; Watts, C. Macropinocytosis. Trends Cell Biol. 1995, 5, 424-428.
150. Kanaseki, T.; Kadota, K. The "vesicle in a basket". A morphological study of the coated vesicle isolated from the nerve endings of the guinea pig brain, with special reference to the mechanism of membrane movements. J. Cell Biol. 1969, 42, 202-220.
151. Woodward, M.P.; Roth, T.F. Coated vesicles: Characterization, selective dissociation, and reassembly. Proc. Natl. Acad. Sci. USA 1978, 75, 4394-4398.
152. Bareford, L.M.; Swaan, P.W. Endocytic mechanisms for targeted drug delivery. Adv. Drug Deliv. Rev. 2007, 59, 748-758.
153. Marsh, M.; Helenius, A. Virus entry: Open sesame. Cell 2006, 124, 729-740.
154. Mayor, S.; Pagano, R.E. Pathways of clathrin-independent endocytosis. Nat. Rev. Mol. Cell Biol. 2007, 8, 602-612.
155. Drummond, D.C.; Meyer, O.; Hong, K.; Kirpotin, D.B.; Papahadjopoulos, D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 1999, 51, 691-743.
156. Chonn, A.; Cullis, P.R. Recent advances in liposomal drug-delivery systems. Curr. Opin. Biotechnol. 1995, 6, 698-708.
157. Mayer, L.D.; Madden, T.M.; Bally, M.B.; Cullis, P.R. pH gradient-mediated drug entrapment in Uposomes. In Liposome Technology, 2nd ed.; Gregoriadis, G., Ed.; CRC Press: Boca Raton, FL, USA, 1993; Volume 2, pp. 27-44.
158. Abdiche, Y.N.; Myszka, D.G. Probing the mechanism of drug/lipid membrane interactions using Biacore. Anal. Biochem. 2004, 328, 233-243.
159. Saito, R.; Krauze, M.T.; Noble, C.O.; Drummond, D.C.; Kirpotin, D.B.; Berger, M.S.; Park, J.W.; Bankiewicz, K.S. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro Oncol. 2006, 8, 205-214.
160. Ostro, M.J. Liposome from biophysics to therapeutics; Marcel Dekker: New York, NY, USA, 1987.
161. Allen, T.M. Liposomal drug formulations. Drugs 1998, 56, 747-756.
162. Iinuma, H.; Murayama, K.; Okinaga, K.; Sasaki, K.; Sekine, T.; Ishida, O.; Ogiwara, N.; Johkura, K.; Yonemura, Y. Intracellular targeting therapy of cisplatin-encapsulated transferring-polyethyleneglycol liposome on peritoneal dissemination of gastric cancer. Int. J. Cancer 2002, 99, 130-137.
163. Saito, R.; Bringas, J.R.; McKnight, T.R.; Wendland, M.F.; Mamot, C.; Drummond, D.C.; Kirpotin, D.B.; Park, J.W.; Berger, M.S.; Bankiewicz, K.S. Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res. 2004, 64, 2572-2579.
164. Noble, C.O.; Krauze, M.T.; Drummond, D.C.; Yamashita, Y.; Saito, R.; Berger, M.S.; Kirpotin, D.B.; Bankiewicz, K.S.; Park, J.W. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Res. 2006, 66, 2801-2806.
165. Saito, R.; Krauze, M.T.; Noble, C.O.; Tamas, M.; Drummond, D.C.; Kirpotin, D.B.; Berger, M.S.; Park, J.W.; Bankiewicz, K.S. Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery. J. Neurosci. Meth. 2006, 154, 225-232.
166. Krauze, M.T.; Noble, C.O.; Kawaguchi, T.; Drummond, D.; Kirpotin, D.B.; Yamashita, Y.; Kullberg, E.; Forsayeth, J.; Park, J.W.; Bankiewicz, K.S. Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Neuro Oncol. 2007, 9, 393-403.
167. Yamashita, Y.; Krauze, M.T.; Kawaguchi, T.; Noble, C.O.; Drummond, D.C.; Park, J.W.; Bankiewicz, K.S. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Neuro Oncol. 2007, 9, 20-28.
168. Dickinson, P.J.; LeCouteur, R.A.; Higgins, R.J.; Bringas, J.R.; Roberts, B.; Larson, R.F.; Yamashita, Y.; Krauze, M.; Noble, C.O.; Drummond, D.; et al. Canine model of convection-enhanced delivery of liposomes containing CPT-11 monitored with real-time magnetic resonance imaging: laboratory investigation. J. Neurosurg. 2008, 108, 989-998.
169. Dickinson, P.J.; LeCouteur, R.A.; Higgins, R.J.; Bringas, J.R.; Larson, R.F.; Yamashita, Y.; Krauze, M.T.; Forsayeth, J.; Noble, C.O.; Drummond, D.C.; et al. Canine spontaneous glioma: A translational model system for convection-enhanced delivery. Neuro Oncol. 2010, 12, 928-940.
170. Krauze, M.T.; Vandenberg, S.R.; Yamashita, Y.; Saito, R.; Forsayeth, J.; Noble, C.; Park, J.; Bankiewicz, K.S. Safety of real-time convection-enhanced delivery of liposomes to primate brain: A long-term retrospective. Exp. Neurol. 2008, 210, 638-644.
171. Krauze, M.; Forsayeth, J.; Yin, D.; Bankiewicz, K.S. Convection-enhanced delivery of liposomes to primate brain. Method Enzymol. 2009, 465, 349-362.
172. Krauze, M.T.; Saito, R.; Noble, C.; Bringas, J.; Forsayeth, J.; McKnight, T.R.; Park, J.; Bankiewicz, K.S. Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen. Exp. Neurol. 2005, 196, 104-111.
173. Grahn, A.Y.; Bankiewicz, K.S.; Dugich-Djordjevic, M.; Bringas, J.R.; Hadaczek, P.; Johnson, G.A.; Eastman, S.; Luz, M. Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience. J. Neuro-Oncol. 2009, 95, 185-197.
174. Hadjipanayis, C.G.; Machaidze, R.; Kaluzova, M.; Wang, L.; Schuette, A.J.; Chen, H.; Wu, X.; Mao, H. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res. 2010, 70, 6303-6312.
175. MacKay, J.A.; Deen, D.F.; Szoka, F.C., Jr. Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating. Brain Res. 2005, 1035, 139-153.
176. Gabizon, A.; Peretz, T.; Sulkes, A.; Amselem, S.; Ben-Yosef, R.; Ben-Baruch, N.; Catane, R.; Biran, S.; Barenholz, Y. Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur. J. Clin. Oncol. 1989, 25, 1795-1803.
177. Noble, C.O.; Kirpotin, D.B.; Hayes, M.E.; Mamot, C.; Hong, K.; Park, J.W.; Benz, C.C.; Marks, J.D.; Drummond, D.C. Development of ligand-targeted liposomes for cancer therapy. Expert Opin. Ther. Targets 2004, 8, 335-353.
178. Allen, T.M.; Hansen, C.B.; Stuart, D.D. Targeted sterically stabilized liposomal drug delivery. In Medical Applications of Liposomes; Lasic, D., Papahadjopoulos, D., Eds.; Elsevier Science B.V.: New York, NY, USA, 1998; pp. 297-323.
179. Barenholz, Y. Liposome application: Problems and prospects. Curr. Opin. Colloid Interface Sci. 2001, 6, 66-77.
180. Drummond, D.C.; Noble, C.O.; Guo, Z.; Hong, K.; Park, J.W.; Kirpotin, D.B. Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy. Cancer Res. 2006, 66, 3271-3277.
181. Ishida, T.; Kiwada, H. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. Int. J. Pharm. 2008, 354, 56-62.
182. Szebeni, J.; Baranyi, L.; Savay, S.; Milosevits, J.; Bunger, R.; Laverman, P.; Metselaar, J.M.; Storm, G.; Chanan-Khan, A.; Liebes, L.; et al. Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: Experimental and clinical studies. J. Liposome Res. 2002, 12, 165-172.
183. Szebeni, J. Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity. Toxicology 2005, 216, 106-121.
184. Harrington, K.J.; Lewanski, C.R.; Stewart, J.S. Liposomes as vehicles for targeted therapy of cancer. Part 1: Preclinical development. Clin. Oncol. 2000, 12, 2-15.
185. Jacobs, A.; Voges, J.; Reszka, R.; Lercher, M.; Gossmann, A.; Kracht, L.; Kaestle, C.; Wagner, R.; Wienhard, K.; Heiss, W.D. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 2001, 358, 727-729.
186. Voges, J.; Reszka, R.; Gossmann, A.; Dittmar, C.; Richter, R.; Garlip, G.; Kracht, L.; Coenen, H.H.; Sturm, V.; Wienhard, K.; et al. Image-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann. Neurol. 2003, 54, 479-487.
187. O'Malley, B.W. Suicide gene therapy. In Gene Therapy for Cancer: Therapeutic Mechanisms and Strategies; Templeton, N., Ed.; Marcel Dekker: New York, NY, USA, 2000; pp. 353-370.
188. Fillat, C.; Carrio, M.; Cascante, A.; Sangro, B. Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. Curr. Gene Ther. 2003, 3, 13-26.
189. Ren, H.; Boulikas, T.; Soling, A.; Warnke, P.C.; Rainov, N.G. Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene-a phase I/II clinical protocol. J. Neuro-Oncol. 2003, 64, 147-154.
190. Chiu, T.L.; Lin, S.Z.; Hsieh, W.H.; Peng, C.W. AAV2-mediated interleukin-12 in the treatment of malignant brain tumors through activation of NK cells. Int. J. Oncol. 2009, 35, 1361-1367.
191. Roche, F.P.; Sheahan, B.J.; O'Mara, S.M.; Atkins, G.J. Semliki Forest virus-mediated gene therapy of the RG2 rat glioma. Neuropathol. Appl. Neurobiol. 2010, 36, 648-660.
192. Huynh, G.H.; Ozawa, T.; Deen, D.F.; Tihan, T.; Szoka, F.C., Jr. Retro-convection enhanced delivery to increase blood to brain transfer of macromolecules. Brain Res. 2007, 1128, 181-190.
193. Myers, R.D.; Rezvani, A.H.; Gurley-Orkin, L.A. New double-lumen polyethylene cannula for push-pull perfusion of brain tissue in vivo. J. Neurosci. Meth. 1985, 12, 205-218.
194. Miyata, S.; Kawabata, S.; Hiramatsu, R.; Doi, A.; Ikeda, N.; Yamashita, T.; Kuroiwa, T.; Kasaoka, S.; Maruyama, K.; Miyatake, S.I. CT imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agent by CED to F98 rat glioma for boron neutron capture therapy. Neurosurgery 2011, in press.
195. Doi, A.; Kawabata, S.; Iida, K.; Yokoyama, K.; Kajimoto, Y.; Kuroiwa, T.; Shirakawa, T.; Kirihata, M.; Kasaoka, S.; Maruyama, K.; et al. Tumor-specific targeting of sodium borocaptate (BSH) to malignant glioma by transferrin-PEG liposomes: A modality for boron neutron capture therapy. J. Neuro-Oncol. 2008, 87, 287-294.
196. Wu, G.; Barth, R.F.; Yang, W.; Lee, R.J.; Tjarks, W.; Backer, M.V.; Backer, J.M. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy. Anti-Cancer Agents Med. Chem. 2006, 6, 167-184.
197. Schroeder, A.; Kost, J.; Barenholz, Y. Ultrasound, liposomes, and drug delivery: Principles for using ultrasound to control the release of drugs from liposomes. Chem. Phys. Lipids 2009, 162, 1-16.